Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Medical Imaging Corp. (MEDD)
Las Vegas, NV, US
Medical Imaging Corp. (MEDD), operating through its various subsidiaries across North America, provides a comprehensive array of diagnostic imaging solutions for a diverse clientele, including individual patients, healthcare facilities, workers' compensation organizations, and insurance carriers. The company also specializes in teleradiology, offering remote analysis and reporting for medical scans. Its robust service portfolio encompasses modalities such as magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), ultrasound, nuclear medicine, digital mammography, X-ray, and bone mineral densitometry. As of the end of 2017, its physical operations included a standalone diagnostic imaging center in Pottsville, Pennsylvania, in addition to three diagnostic facilities located throughout Florida. Established in 2000 and headquartered in Las Vegas, Nevada, the enterprise adopted its current name, Medical Imaging Corp., in July 2014, having previously operated as Diagnostic Imaging International Corp.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | -50.00% | -50.00% | +0.00% | +0.00% | +0.00% | -50.00% | -98.61% | -99.90% | -99.98% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Diagnostics & Research: +7.9%+0.6%
-
EPS growth Medical - Diagnostics & Research: +30.8%-92.3%
-
FCF margin FCF growth · Medical - Diagnostics & Research: +32.2%-25.3%
-
EBIT margin Medical - Diagnostics & Research: +9.6%-20.4%
-
ROIC Medical - Diagnostics & Research: +5.2%—
-
Share dilution Medical - Diagnostics & Research: 0.0%+13.7%
-
Debt / EBITDA Net debt/EBITDA · Medical - Diagnostics & Research: -0.13×-4.27×
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Mitchell Geisler | Chief Executive Officer, Chief Financial Officer, President & Chairman | 122.4K | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MEDD
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
